Women In Oncology

The literature shows that most CME speakers are men and that “manels” are still too common.

Although most academic and nonacademic female oncologists reported they would choose the same career path again, about 20% of those in academia said they were likely to soon pursue a career outside that setting, according to a survey.

Neelima Denduluri, MD, moved from a large breast oncology practice and research in clinical trials to industry because she sought to expand her skill set and greaten her impact.

There are many major life events that can be as exciting as they are demanding, such as starting the next step in a career or having a child — both of which two oncologist colleagues experienced around the same time.

When some patients with cancer may have limited life expectancies, taking time off as an oncologist can be all the more complicated.

Women represented fewer first, last and corresponding authors during the early period of the pandemic, especially on COVID-19-related manuscripts, compared with other periods, according to a study published in The British Medical Journal.

Women in academic medicine found promotion and tenure processes to be characterized by inconsistency or ambiguous criteria, exacerbated by long-standing gender disparities, according to data published in JAMA Network Open.

Women are more likely to feel uncomfortable than men to ask for more time on adjustable deadlines at work or school, leading to higher rates of time stress and burnout, according to study results.

Healio’s Women in Oncology series has addressed a multitude of gender equity issues in medicine among health care professionals, but Kristina Jenei, BSN, MSc, has also found that underrepresentation of women is present among trials.

The William L. McGuire Lecture Award will be presented to Olufunmilayo Olopade, MD, FAACR, at San Antonio Breast Cancer Symposium this month.